Clinical Trials Logo

ACC clinical trials

View clinical trials related to ACC.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06066333 Recruiting - Clinical trials for Adrenocortical Carcinoma

Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma

Start date: September 27, 2023
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether pembrolizumab given after standard ablative Radiotherapy is a safe treatment that causes few or mild side effects in people with advanced Adrenocortical Carcinoma.